BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23325107)

  • 1. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.
    Jiang TF; Zhang YJ; Zhou HY; Wang HM; Tian LP; Liu J; Ding JQ; Chen SD
    J Neuroimmune Pharmacol; 2013 Mar; 8(1):356-69. PubMed ID: 23325107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats.
    Yu L; Hu X; Xu R; Zhao Y; Xiong L; Ai J; Wang X; Chen X; Ba Y; Xing Z; Guo C; Mi S; Wu X
    J Ethnopharmacol; 2024 Mar; 322():117628. PubMed ID: 38158101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway.
    Yan JQ; Yuan YH; Gao YN; Huang JY; Ma KL; Gao Y; Zhang WQ; Guo XF; Chen NH
    Mol Neurobiol; 2014 Oct; 50(2):685-701. PubMed ID: 24833599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Hsp90 Inhibitor Activates Compensatory Heat Shock Protein Responses and Autophagy and Alleviates Mutant A53T α-Synuclein Toxicity.
    Xiong R; Zhou W; Siegel D; Kitson RR; Freed CR; Moody CJ; Ross D
    Mol Pharmacol; 2015 Dec; 88(6):1045-54. PubMed ID: 26405178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling.
    Chen S; Cai F; Wang J; Yang Z; Gu C; Wang G; Mao G; Yan J
    Mol Med Rep; 2019 Jul; 20(1):529-538. PubMed ID: 31180515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation.
    Huang Y; Chegini F; Chua G; Murphy K; Gai W; Halliday GM
    Transl Neurodegener; 2012 Jan; 1(1):2. PubMed ID: 23210740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
    Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X
    Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant α-synuclein.
    Lan DM; Liu FT; Zhao J; Chen Y; Wu JJ; Ding ZT; Yue ZY; Ren HM; Jiang YP; Wang J
    Neurochem Res; 2012 Sep; 37(9):2025-32. PubMed ID: 22707286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy.
    Sheng YL; Chen X; Hou XO; Yuan X; Yuan BS; Yuan YQ; Zhang QL; Cao X; Liu CF; Luo WF; Hu LF
    Exp Neurol; 2017 Nov; 297():138-147. PubMed ID: 28821398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of Parkinson's Disease-Like Deficits by Activating Autophagy through mTOR-Dependent and mTOR-Independent Mechanisms in Pharmacological and Transgenic Models of Parkinson's Disease in Mice.
    Pupyshev AB; Tenditnik MV; Ovsyukova MV; Akopyan AA; Dubrovina NI; Tikhonova MA
    Bull Exp Biol Med; 2021 Aug; 171(4):425-430. PubMed ID: 34542745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model.
    Gan L; Vargas MR; Johnson DA; Johnson JA
    J Neurosci; 2012 Dec; 32(49):17775-87. PubMed ID: 23223297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant α-synuclein.
    Lan D; Wang W; Zhuang J; Zhao Z
    Mol Med Rep; 2015 Mar; 11(3):1655-60. PubMed ID: 25434876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.
    Xilouri M; Vogiatzi T; Vekrellis K; Park D; Stefanis L
    PLoS One; 2009; 4(5):e5515. PubMed ID: 19436756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro modulation of mTOR and mGlur5 influence α-synuclein accumulation.
    Xing V; Biggar K; Ferguson SSG; Hayley S
    Mol Brain; 2024 Feb; 17(1):9. PubMed ID: 38360671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasudil Promotes α-Synuclein Clearance in an AAV-Mediated α-Synuclein Rat Model of Parkinson's Disease by Autophagy Activation.
    Yang YJ; Bu LL; Shen C; Ge JJ; He SJ; Yu HL; Tang YL; Jue Z; Sun YM; Yu WB; Zuo CT; Wu JJ; Wang J; Liu FT
    J Parkinsons Dis; 2020; 10(3):969-979. PubMed ID: 32568105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.